PMEF
ABBV icon

Point72 Middle East FZE’s AbbVie ABBV Stock Holding History

Point72 Middle East FZE’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-125,199
Closed -$19.4M – 9
2023
Q4 		$19.4M Sell
125,199
-59,653
-32% -$8.7M 0.57% 17
2023
Q3 		$27.6M Buy
184,852
+54,997
+42% +$8.07M 0.9% 7
2023
Q2 		$17.5M Buy
+129,855
New +$19M 0.49% 33

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Point72 Middle East FZE's ABBV Position: Q1 2024 in Review

Point72 Middle East FZE sold out of AbbVie (ABBV) in Q1 2024, closing a stake of 125,199 shares — an estimated $19.4M sold.

Point72 Middle East FZE first reported a position in ABBV in Q2 2023 and held it in 3 quarters. The position peaked at $27.6M in Q3 2023. 3,379 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.

  • Point72 Middle East FZE reported no remaining AbbVie position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 125,199 AbbVie shares in Q1 2024, an estimated $19.4M.
  • Point72 Middle East FZE first reported a position in AbbVie in Q2 2023 and held it in 3 quarters.
  • Point72 Middle East FZE's AbbVie position peaked at $27.6M in Q3 2023.
  • 3,379 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.